Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO
Published inBMC cancer, vol. 21, no. 1, 1158
Publication date2021-10-29
First online date2021-10-29
Abstract
Keywords
- Cisplatin
- FLOT- regimen
- Gastrectomy
- Gastric cancer
- Gastroesophageal junction cancer
- HIPEC
- Hyperthermic intraperitoneal chemotherapy
- Lauren- classification
- Peritoneal carcinomatosis
- Quality of life
- Signet ring cells
Affiliation
Research group
Funding
- Deutsche Krebshilfe (German Cancer Aid) - [70113137]
Citation (ISO format)
GÖTZE, Thorsten O et al. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III ‘PREVENT’- (FLOT9) trial of the AIO /CAOGI /ACO. In: BMC cancer, 2021, vol. 21, n° 1, p. 1158. doi: 10.1186/s12885-021-08872-8
Main files (1)
Article (Published version)
Identifiers
- PID : unige:158684
- DOI : 10.1186/s12885-021-08872-8
- PMID : 34715810
- PMCID : PMC8555172
ISSN of the journal1471-2407